Global CD Targeted Cell Therapy Market

Report ID : 1134 | Published : 2021-07-27 | Pages: 140 | Format:

 InsightAce Analytic’s “Global CD Targeted Cell Therapy Market Research Report 2021” is a comprehensive analysis, forecast, market dynamics, and major trends report, covering critical market data on the CD targeted cell therapy target type segments. This market research report provides market estimation and forecast for value (US$), within CD targeted cell therapy market segments.

CD Targeted Cell Therapies is one of the fastest advancing technology along with huge research and development activities. The oncology market today could be quickly superseded by next-generation therapies in the upcoming forecast period. The CD-targeted cell therapy market is driven by increasing research funding in the immune-oncology, rising prevalence of cancer, and increasing focus on research activities from government health institutions and pharma giants in Immuno-oncology therapy development.

The Global CD Targeted Cell Therapy Market is segmented on the basis of indication type, target type, and region. Based on the indication type, the CD targeted cell therapy market is divided into Diffuse large B-cell lymphoma, Chronic lymphocytic leukemia, Multiple myeloma, Acute lymphoblastic leukemia, and Others. Based on the target type, the CD targeted cell therapy market is divided into CD19, CD20, and CD33. Based on region, the market is studied across North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the CD Targeted Cell Therapy Market during the analysis of the forecast period.

The key players of CD targeted cell therapy market include Juno Therapeutics, Agios Pharmaceutical, Aurora BioPharma, Atara Biotherapeutics, AryoGen Biopharma, Shenzhen BinDeBio Ltd., China Immunotech Co., Ltd., Autolus Limited, Kite Pharma, Bellicum Pharmaceuticals, bluebird bio,Calibr, Carina Biotech, CARsgen Therapeutics, Celgene Corporation, Cellectis, Cell Medica, AbbVie, Allogene Therapeutics, Amgen, Cell Design Labs, Celularity, Celyad, Fate Therapeutics, Fortress Bio, Gilead Sciences, Sorrento Therapeutics, Inc., Ziopharm,Janssen Biotech, JW Therapeutics, Medisix Therapeutics, Mustang Bio, Nanjing Legend Biotech, Precision Biosciences, and Posedia Therapeutics

Key insights included in the report

  • This InsightAce Analytic report will help to develop sales strategies by understanding the trends shaping and driving
  • Organize marketing and sales efforts by identifying the best opportunities for CD Targeted Cell Therapy Market
  • This report offers analysis or key insights to understand the future market competition in the CD-targeted cell therapy market.
  • Key features of CD targeted cell therapy product which makes them a better choice over substitute product with the inclusion of Porter’s Five Forces Analysis
  • How did the CD targeted cell therapy market evolve, and what is its scope in the future
  • Key development strategies which the key players implement to maintain and capture market share
  • Analysis of major market drivers, challenges, and opportunities in the global CD targeted cell therapy market
  • Insights on the current leading companies dominating the global CD targeted cell therapy market
  • The market analysis and forecast of the leading segments and sub-segments of the global CD targeted cell therapy industry
  • Analysis of each segment of the global CD targeted cell therapy market expected to grow during the forecast period 2018-2028.
  • Analysis of geographic region that carries the potential for the significant expansion of key companies for CD targeted cell therapy market

 

  • Juno Therapeutics
  • Agios Pharmaceutical
  • Aurora BioPharma
  • Atara Biotherapeutics
  • AryoGen Biopharma
  • Shenzhen BinDeBio Ltd.
  • China Immunotech Co., Ltd.
  • Autolus Limited
  • Kite Pharma
  • Bellicum Pharmaceuticals
  • bluebird bio
  • Calibr
  • Carina Biotech
  • CARsgen Therapeutics
  • Celgene Corporation
  • Cellectis
  • Cell Medica
  • AbbVie
  • Allogene Therapeutics
  • Amgen
  • Cell Design Labs
  • Celularity
  • Celyad
  • Fate Therapeutics
  • Fortress Bio
  • Gilead Sciences
  • Sorrento Therapeutics, Inc.
  • Ziopharm
  • Janssen Biotech
  • JW Therapeutics
  • Medisix Therapeutics
  • Mustang Bio
  • Nanjing Legend Biotech
  • Precision Biosciences
  • Posedia Therapeutics

Global CD Targeted Cell Therapy Market Segmentation:

Global CD Targeted Cell Therapy Market by Indication Type

  • Diffuse large B-cell lymphoma
  • Chronic lymphocytic leukemia
  • Multiple myeloma
  • Acute lymphoblastic leukemia
  • Others

Global CD Targeted Cell Therapy Market by Target Type

  • CD19
  • CD20
  • CD33

Global CD Targeted Cell Therapy Market Based on Region

Europe CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

  • U.S.
  • Canada

Asia Pacific CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa CD Targeted Cell Therapy Market Outlook 2019-2030 by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients